碘海醇雜質(zhì)Ⅱ(5-乙酰胺基-N,N’-雙(2,3-二羥丙基)-2,4,6-三碘-1,3-苯二甲酰胺)
|
PCL-#-Chp0442-50mg
|
≥95% 雜質(zhì)對照品 |
31127-80-7 |
50mg
|
咨詢
|
咨詢 |
PCL |
碘海醇雜質(zhì)Ⅱ(5-乙酰胺基-N,N’-雙(2,3-二羥丙基)-2,4,6-三碘-1,3-苯二甲酰胺)
|
PCL-#-Chp0442-25mg
|
≥95% 雜質(zhì)對照品 |
31127-80-7 |
25mg
|
咨詢
|
咨詢 |
PCL |
碘海醇雜質(zhì)Ⅰ (5-氨基-N,N’-雙(2,3-二羥丙基)-2,4,6-三碘-1,3-苯二甲酰胺)
|
PCL-#-Chp0441-50mg
|
≥95% 雜質(zhì)對照品 |
76801-93-9 |
50mg
|
咨詢
|
咨詢 |
PCL |
碘海醇雜質(zhì)Ⅰ (5-氨基-N,N’-雙(2,3-二羥丙基)-2,4,6-三碘-1,3-苯二甲酰胺)
|
PCL-#-Chp0441-25mg
|
≥95% 雜質(zhì)對照品 |
76801-93-9 |
25mg
|
咨詢
|
咨詢 |
PCL |
碘佛醇雜質(zhì)Ⅱ(N,N'-雙(2,3-二羥丙基)-5-(2-(2-羥乙酰胺基)-2-氧代乙氧基)- 2,4,6-三碘-1,3-苯二甲酰胺)
|
PCL-#-Chp0440-50mg
|
≥95% 雜質(zhì)對照品 |
104517-96-6 |
50mg
|
咨詢
|
咨詢 |
PCL |
碘佛醇雜質(zhì)Ⅱ(N,N'-雙(2,3-二羥丙基)-5-(2-(2-羥乙酰胺基)-2-氧代乙氧基)- 2,4,6-三碘-1,3-苯二甲酰胺)
|
PCL-#-Chp0440-25mg
|
≥95% 雜質(zhì)對照品 |
104517-96-6 |
25mg
|
咨詢
|
咨詢 |
PCL |
碘佛醇雜質(zhì)Ⅰ(N,N'-雙(2,3-二羥基丙基)-5-氨基-2,4,6-三碘-1,3- 苯二甲酰胺)
|
PCL-#-Chp0439-50mg
|
≥95% 雜質(zhì)對照品 |
76801-93-9 |
50mg
|
咨詢
|
咨詢 |
PCL |
碘佛醇雜質(zhì)Ⅰ(N,N'-雙(2,3-二羥基丙基)-5-氨基-2,4,6-三碘-1,3- 苯二甲酰胺)
|
PCL-#-Chp0439-25mg
|
≥95% 雜質(zhì)對照品 |
76801-93-9 |
25mg
|
咨詢
|
咨詢 |
PCL |
賴諾普利雜質(zhì)Ⅰ(2-氨基-4-苯基丁酸)
|
PCL-#-Chp0438-50mg
|
≥95% 雜質(zhì)對照品 |
1012-05-1 |
50mg
|
咨詢
|
咨詢 |
PCL |
賴諾普利雜質(zhì)Ⅰ(2-氨基-4-苯基丁酸)
|
PCL-#-Chp0438-25mg
|
≥95% 雜質(zhì)對照品 |
1012-05-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
蒿甲醚雜質(zhì)Ⅲ{2-[4-甲基-2-氧代-3-(3-氧代丁基)環(huán)己基]丙醛}
|
PCL-#-Chp0437-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0437-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
蒿甲醚雜質(zhì)Ⅲ{2-[4-甲基-2-氧代-3-(3-氧代丁基)環(huán)己基]丙醛}
|
PCL-#-Chp0437-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0437-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
蒿甲醚雜質(zhì)Ⅱ((3aS,4R,6aS,7R,8S,10R,10aR)[1]-8-甲氧基-4,7-二甲基八氫-2H-呋喃并[3,2-i][2]苯并吡喃-10-醇醋酸酯)
|
PCL-#-Chp0436-50mg
|
≥95% 雜質(zhì)對照品 |
181528-64-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
蒿甲醚雜質(zhì)Ⅱ((3aS,4R,6aS,7R,8S,10R,10aR)[1]-8-甲氧基-4,7-二甲基八氫-2H-呋喃并[3,2-i][2]苯并吡喃-10-醇醋酸酯)
|
PCL-#-Chp0436-25mg
|
≥95% 雜質(zhì)對照品 |
181528-64-3 |
25mg
|
咨詢
|
咨詢 |
PCL |
蒿甲醚雜質(zhì)Ⅰ(α-蒿甲醚)
|
PCL-#-Chp0435-50mg
|
≥95% 雜質(zhì)對照品 |
71939-51-0 |
50mg
|
咨詢
|
咨詢 |
PCL |
蒿甲醚雜質(zhì)Ⅰ(α-蒿甲醚)
|
PCL-#-Chp0435-25mg
|
≥95% 雜質(zhì)對照品 |
71939-51-0 |
25mg
|
咨詢
|
咨詢 |
PCL |
富馬酸福莫特羅雜質(zhì)Ⅰ(非對映異構(gòu)體)
|
PCL-#-Chp0434-50mg
|
≥95% 雜質(zhì)對照品 |
532414-36-1 |
50mg
|
咨詢
|
咨詢 |
PCL |
富馬酸福莫特羅雜質(zhì)Ⅰ(非對映異構(gòu)體)
|
PCL-#-Chp0434-25mg
|
≥95% 雜質(zhì)對照品 |
532414-36-1 |
25mg
|
咨詢
|
咨詢 |
PCL |
普伐他汀鈉雜質(zhì)Ⅲ(普伐他汀內(nèi)酯)
|
PCL-#-Chp0433-50mg
|
≥95% 雜質(zhì)對照品 |
85956-22-5 |
50mg
|
咨詢
|
咨詢 |
PCL |
普伐他汀鈉雜質(zhì)Ⅲ(普伐他汀內(nèi)酯)
|
PCL-#-Chp0433-25mg
|
≥95% 雜質(zhì)對照品 |
85956-22-5 |
25mg
|
咨詢
|
咨詢 |
PCL |
普伐他汀鈉雜質(zhì)Ⅱ(普伐他汀3α-羥基異構(gòu)體)
|
PCL-#-Chp0432-50mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0432-N/A |
50mg
|
咨詢
|
咨詢 |
PCL |
普伐他汀鈉雜質(zhì)Ⅱ(普伐他汀3α-羥基異構(gòu)體)
|
PCL-#-Chp0432-25mg
|
≥95% 雜質(zhì)對照品 |
PCL-#-Chp0432-N/A |
25mg
|
咨詢
|
咨詢 |
PCL |
普伐他汀鈉平雜質(zhì)Ⅰ(6-表普伐他汀)
|
PCL-#-Chp0431-50mg
|
≥95% 雜質(zhì)對照品 |
151006-14-3 |
50mg
|
咨詢
|
咨詢 |
PCL |
普伐他汀鈉平雜質(zhì)Ⅰ(6-表普伐他?。?
|
PCL-#-Chp0431-25mg
|
≥95% 雜質(zhì)對照品 |
151006-14-3 |
25mg
|
咨詢
|
咨詢 |
PCL |